Martini Clinic, in the University Hospital Eppendorf (UKE) campus in Hamburg, is one of the world's major centres for nerve-sparing prostatectomy. The Martini physicians not only specialise in surgical intervention but are also at the cutting edge of diagnostics, being among the few in Germany to use sono-elastography, an innovative tool to detect prostate cancer. We asked Dr Georg Salomon (GS),…
Siemens Healthcare will show its Acuson S2000, the first ultrasound system in the new product series S, at the ESC*. The system platform includes integration of the newest technologies to optimise workflow, e.g. comprehensive software applications such as new software for breast imaging.
`High performance systems need not be large,´ says Aloka, manufacturer of the new compact ProSound a7, which produces high-resolution images yet can be used in areas with little spare space. `Broadband Harmonics provides high sensitivity and penetration that is comparable to fundamental-frequency imaging resulting in a significant improvement above standard harmonic imaging,´ Aloka reports.
Philips has added a new platform to its HD ultrasound products - the HD15 - which aims to provide small hospitals, clinics and private practices with advanced image clarity and broad application support for everyday use.
What is the role of vascular ultrasound in stroke prevention? Asked by Karoline Laarmann of European Hospital, Professor Christian Arning MD, Medical Director of the Neurology Department at Asklepios Klinik Wandsbek, Germany, and Deputy Chairman of the German Society of Ultrasound in Medicine (DEGUM), gave an unequivocal answer: crucial - but only if the sonographer is properly qualified.
Although ultrasound imaging is a very powerful imaging modality it is mostly under-used Ultrasound combines several very appealing characteristics. It is among the non-invasive imaging modalities, indeed it is really non-invasive. Similar to MRI, no harm to the patient can be caused by ultrasound.
Almost 25 years ago Michael Harrison of the University of California, San Francisco (UCSF) operated on the bladder of an unborn child. Almost eight years later, surgery was carried out on the diaphragm of an unborn child. His approach was controversial: a paediatric surgeon opened the abdomen and uterus of the pregnant woman, lifted out the foetus, performed the surgery and returned the foetus to…
An emerging discipline of noninvasive cardiac imaging, molecular imaging, has evolved constantly in the last few years and is increasingly being translated from the preclinical to the clinical level. Molecular imaging allows for unique insights into specific disease mechanisms and holds great promise to change the practice of cardiovascular medicine by facilitating early disease detection,…
While treadmill exercise stress testing is essential to detect cardiovascular disease, gaining clear cardiac images at peak stress level are not easy to gain using standard testing procedures. Now, however, researchers at the Ohio State University Medical Centre have designed equipment to provide high-resolution cardiac images at a critical testing stage, with results in under one hour.
Atlanta-based Velocity Medical Solutions launched VelocityAI, its new molecular imaging software, at the 2008 American Association of Physicists Medicine (AAPM) in July.
Last October the Food and Drugs Administration (FDA) added a black box warning on ultrasound (US) contrast agents used in echocardiogram imaging examinations, around 200 reports of serious allergic reactions were received. Problems included cardiac arrest as well as breathing difficulty and seizures; seven of the cases resulted in death.
The belief that iodinated contrast agents can induce nephropathy has been held for many years, even though most of the clinical literature has not been able to distinguish contrast-induced nephropathy from other causes of the condition.
The drug information system AiDKlinik developed by Dosing GmbH is a software solution for the server-based intranet for medication dosing.
The first robotised tele-ultrasound examination has been performed by participants in the European Mobile And Robotised Tele-echography (MARTE) project, in collaboration with Robosoft, specialist in the development and production of service robot systems.
Pegasus/Heartview LLC has announced that clinical studies of its HeartVue 6S Heart Screening System - which obtained CE Mark Approval in Europe almost two years ago - have been completed according to FDA guidelines, as a pre-marketing condition for release in the USA.
St. Jude Medical, Inc. has received European CE Mark approval and US Food and Drug Administration (FDA) clearance for its Epicor LP cardiac ablation system, a second generation technology that uses HIFU (high intensity focused ultrasound) for surgical ablation of cardiac tissue to disrupt abnormal cardiac electrical impulses.
Stefan G Ruehm, Kambiz Nael, Derek Lohan and Henrik J Michaely* describe impressive images that benefit patient treatment
Royal Philips Electronics is to lead `euHeart´, the new European Union (EU) funded research project that aims to improve CVD diagnosis, therapy planning and treatment.
Every summer the European Society of Cardiology (ESC) holds Europe's biggest annual meeting of specialists in cardiovascular medicine, inviting and drawing in top international medical professionals. Karoline Laarmann asked Professor Kim Fox, President of the European Society of Cardiology and Consultant Cardiologist at the Royal Brompton Hospital, and professor of clinical cardiology at Imperial…
More than 4,500 cancer and radiotherapy specialists will gather in Göteborg, Sweden, this September for the 27th annual congress of ESTRO. ESTRO 27 is to be held between the 14th and 18th September 2008 at the Göteborg Convention Centre in Göteborg.
A new study reveals that, with dual-source computed tomography (DSCT), the effective dosage for a heart examination can be significantly lowered, in comparison to conventional computed tomography (CT). The study also demonstrated that stenoses can be diagnosed with the same high accuracy as with invasive x-ray angiography.
US- researchers found that inpatients experience an average of nearly one and a half potentially harmful errors in their medication record during a hospital stay. They started the search for the causes: admission and discharging are the most dangerous situations.
Women who survive breast cancer for at least five years have a 89% chance that it will not recure. But those, who are still suffering and on endocrine treatment are likely to get arthralgia and arthritis.